Effects of Statins to Reduce All-Cause Mortality in Heart Failure Patients: Findings from the EPICAL2 Cohort Study.
Fiche publication
Date publication
avril 2019
Journal
American journal of cardiovascular drugs : drugs, devices, and other interventions
Auteurs
Membres identifiés du Cancéropôle Est :
Pr THILLY Nathalie
Tous les auteurs :
Al-Gobari M, Agrinier N, Soudant M, Burnand B, Thilly N
Lien Pubmed
Résumé
The addition of statins to standard care in heart failure (HF) patients remains controversial in clinical practice. Large-scale clinical trials failed to show mortality benefits, but uncertainty persists in real-world settings.
Référence
Am J Cardiovasc Drugs. 2019 Apr 10;: